4d Pharma Plc Long Term Debt

4d Pharma Plc (LBPS) currently reports a long-term debt of $13M as of December 2021. That compares with $990K in the prior-year period — up 1187.6% year over year. Use the charts on this page to explore 4d Pharma Plc's long-term debt history and peer comparisons.

4d Pharma Plc's long-term debt increased from $990K to $13M — a 1187.6% year-over-year increase (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

4d Pharma Plc reported $13M in long-term debt as of December 2021. That compares with $990K in the prior-year period — up 1187.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 4d Pharma Plc, and consider following LBPS for alerts when major investors trade the stock.

4d Pharma Plc is classified in the Healthcare sector. On long-term debt, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LBPS with unrelated industries.